Mumbai, April 6 -- The board of Aurobindo Pharma at its meeting held on 06 April 2026 has approved buyback of up to 54,23,728 fully paid up equity shares of face value of Re 1 each (0.93% of paid up equity share capital) at a price of Rs 1,475 per equity share payable in cash for an aggregate amount of Rs 800 crore.

Published by HT Digital Content Services with permission from Capital Market....